Cytokinetics Inc. buy Wells Fargo & Company
Start price
07.05.26
/
50%
€63.48
Target price
07.05.27
€89.31
Performance (%)
5.36%
Price
31.07.26
€66.88
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 5.36%. This prediction currently runs until 07.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -5.803% | -5.803% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Wells Fargo & Company from $95.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.40
10.04.26
10.04.26
€81.26
10.04.27
10.04.27
20.72%
31.07.26
31.07.26
